NRGENE ASSEMBLES FIRST ACCURATE BUCKWHEAT GENOME
July 11, 2018
Ness Ziona, Israel – Buckwheat researchers from Japan now have access to the most accurate genome available, thanks to NRGene. The project was done with Dr. Yasuo Yasui, a renowned buckwheat scientist, in cooperation with GeneBay, NRGene’s partner in Japan. The results were presented yesterday at the annual meeting of the Society for Molecular Biology [...]
July 11, 2018
Under this agreement, MaxCyte’s second signed with a U.S. NIH institute in the past year, the Company and the National Heart, Lung, and Blood Institute will explore development of new therapies for sickle cell disease using MaxCyte’s gene-correction platform Gaithersburg, Maryland – MaxCyte, Inc. today announces it has entered into a Cooperative Research and Development Agreement (“CRADA”) [...]
Porvair: Sintered Porous Materials for High Performance Chromatography
July 11, 2018
Porvair is a leading developer and manufacturer of sintered porous materials that offer optimum solutions in a wide range of applications. Developed for the Bioscience market - BioVyon™ is a high-performance porous polymeric material manufactured to the highest cleanliness standards. This unique material, produced from high-density polyethylene resin using a proprietary process that can be [...]
QIAGEN partners with U.K. to expand biomarker research in Manchester
July 11, 2018
Public-private alliances will create world-leading genomics campus and accelerate commercialization Manchester, United Kingdom, and Hilden, Germany – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a partnership with multiple organizations to support creating a global genomics campus in Manchester, U.K., for innovation, life sciences, translational science and molecular diagnostics. QIAGEN is working with Health [...]
July 11, 2018
Shimadzu Corporation (hereinafter “Shimadzu") has signed an agreement to acquire all shares of infraserv Vakuumservice GmbH (hereinafter "IVG"), which is involved in servicing turbomolecular pumps in Europe. After completion of the required acquisition process, IVG will be our wholly owned subsidiary in July. Background and Purpose of Acquisition In the semiconductor market expected to further [...]
KromaTiD Inc. Joins the National Institute of Standards and Technology Genome Editing Consortium
July 11, 2018
FORT COLLINS, Colo. -- KromaTiD, Inc. announced today that it has joined the National Institute of Standards and Technology Genome Editing Consortium, a newly launched public/private partnership (https://www.nist.gov/programs-projects/nist-genome-editing-consortium). The Consortium supports the emerging gene editing market and regulatory agency needs for standardized measurements of gene edits, editing by-products and the risks of utilizing genome editing technologies in research, [...]
Rigaku Analytical Devices Chosen for Project Global Shield, a World Customs Organization Program
July 11, 2018
Progeny ResQ 1064nm handheld Raman analyzers selected to support global efforts to counter illicit diversion and trafficking of precursor chemicals used in explosive devices Wilmington, Massachusetts – Rigaku Analytical Devices, a leader in advanced handheld and portable spectroscopic analyzers, has been chosen to provide its Progeny ResQ system to be used in Project Global Shield, a World Customs Organization (WCO) [...]
DNA Script awarded $2.7M in Innovation Grants From Bpifrance
July 10, 2018
Total Financing Raised to Date Is $27M Paris, France - DNA Script announced today it has been awarded $2.7M in non-dilutive financing from the "Concours d'Innovation" program of Bpifrance. DNA Script was awarded this financing, to be received as subsidies and refundable advances, based on the promise of the company's innovative enzymatic DNA synthesis technology and [...]
908 Devices and Hangzhou Just Biotherapeutics Announce Joint Innovation Partnership
July 10, 2018
908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecular analysis, today announced a joint innovation partnership with Hangzhou Just Biotherapeutics (HJB). HJB is an integrated design company focused on technologies that will accelerate development of biotherapeutics and reduce manufacturing costs to make medicines more readily available in the global marketplace. HJB partners with [...]
July 10, 2018
Library of ~850 pre-synthesized gene targets and novel target enrichment technology supports rapid customization across a variety of panel sizes and content IPSWICH, MA — New England Biolabs (NEB®) today announced the launch of the NEBNext Direct Custom Ready Panels. The new panels — coupled with the proprietary NEBNext Direct target enrichment technology — enable [...]

